Sonic hedgehog gene-enhanced tissue engineering for bone regeneration

Gene Therapy

Volumn 12, Issue 1, 2005, Pages 75-86

  Edwards, P C ^a,d   Ruggiero, S ^a   Fantasia, J ^a   Burakoff, R ^a   Moorji, S M ^b   Paric, E ^b   Razzano, P ^c   Grande, D A ^c   Mason, J M ^b  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b Department of Medicine   (United States)

^c Creighton University Medical Center ^*  (United States)

^d CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Fat derived stem cells; Gene enhanced bone regeneration; Gingival fibroblasts; Periosteal derived cells; Retroviral expression vector; Sonic hedgehog

Indexed keywords

ALGINIC ACID; BETA ACTIN; COLLAGEN TYPE 1; COMPLEMENTARY DNA; GELFOAM; MATRIGEL; RETROVIRUS VECTOR; RNA; SONIC HEDGEHOG PROTEIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BONE REGENERATION; CELL BASED GENE THERAPY; CELL POPULATION; CONTROLLED STUDY; DNA ISOLATION; DRUG MECHANISM; ENHANCER REGION; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; FETUS LUNG; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSDUCTION; GINGIVA; HUMAN; HUMAN TISSUE; LONG TERMINAL REPEAT; MALE; MESENCHYMAL STEM CELL; MOLECULAR CLONING; MURINE LEUKEMIA VIRUS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REGENERATIVE ABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKULL DEFECT; STATISTICAL SIGNIFICANCE; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADIPOSE TISSUE; ANIMALS; BONE REGENERATION; CELL TRANSPLANTATION; FIBROBLASTS; GENE THERAPY; GENETIC VECTORS; GINGIVA; HEDGEHOG PROTEINS; HUMANS; MESENCHYMAL STEM CELLS; RABBITS; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ENGINEERING; TRANS-ACTIVATORS; TRANSDUCTION, GENETIC;

ERINACEIDAE; MURINAE; MURINE LEUKEMIA VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 11844281480     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302386     Document Type: Article

References (48)

1. Zellin G. Growth factors and bone regeneration. Swed Dent J 1998; 129: 7-65.
2. Ebara S, Nakayama K. Mechanisms for the action of bone morphogenetic proteins and regulation of their activity. Spine 2002; 27: S10-S15.
3. Yoshida K et al. Enhancement by recombinant human bone morphogenetic protein-2 of bone formation by means of porous hydroxyapatite in mandibular bone defects. J Dent Res 1999; 78 1505-1510.
4. Miyaji H et al. Hard tissue formation on dentin surfaces applied with recombinant human bone morphogenetic protein-2 in the connective tissue of the palate. J Periodont Res 2002; 37 204-209.
5. Suzuki T et al. Regeneration of defects in the articular cartilage in rabbit temporomandibular joints by bone morphogenetic protein-2. Brit J Oral Maxillofac Surg 2002; 40 201-206.
6. Wozney JM. Overview of bone morphogenetic protein. Spine 2002; 27: S2-S8.
7. Groeneveld EH, Burger EH. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol 2000; 142: 9-21.
8. Valentin-Opran A et al. Clinical evaluation of recombinant bone morphogenetic protein-2. Clin Orthopaed Rel Res 2002; 395: 110-120.
9. Spinella-Jaegle S et al. Sonic Hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. J Cell Sci 2001; 114 2085-2094.
10. St-Jacques B et al. Sonic hedgehog signaling is essential for hair development. Curr Biol 1998; 8: 1058-1068.
11. Peters H, Balling R. Teeth: where and how to make them. Trends Genet 1999; 15: 59-65.
12. Dassule HR et al. Sonic hedgehog regulates growth and morphogenesis of the tooth. Development 2000; 127: 4775-4785.
13. Chiang C et al. Cyclopia and defective axial patterning in mice lacking sonic hedgehog gene function. Nature 1996; 383 407-413.
14. Hu D, Helms JA. The role of Sonic hedgehog in normal and abnormal craniofacial morphogenesis. Development 1999; 126: 4873-4884.
15. Nanni L et al. SHH mutation is associated with solitary median maxillary central incisor: a study of 13 patients and review of the literature. Am J Med Genet 2001; 102: 1-10.
16. Kinto N et al. Fibroblasts expressing sonic hedgehog induce osteoblast differentiation and ectopic bone formation. FEBS Lett 1997; 404: 319-323.
17. Kato M et al. Identification of Sonic Hedgehog-responsive genes using cDNA microarray. Biochem Biophys Res Comm 2001; 298: 472-478.
18. Nybakken K, Perrimon N. Hedgehog signal transduction: recent findings. Curr Opin Genet Develop 2002; 12: 503-511.
19. Bitgood MJ, McMahon AF. Hedgehog and BMP genes are co-expressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev Biol 1995; 172: 126-138.
20. Ohsaki K, Osumi N, Nakamura S. Altered whisker patterns induced by ectopic expression of SHH are topographically represented by barrels. Dev Brain Res 2002; 137: 159-170.
21. Enamoto-Iwamoto M et al. Hedgehog proteins stimulate chondrogenic cell differentiation and cartilage formation. J Bone Min Res 2000; 15: 1659-1668.
22. Yuasa T et al. Sonic Hedgehog is involved in osteoblast differentiation by cooperating with BMP-2. J Cell Physiol 2002; 193: 225-232.
23. Goetz JA, Suber LM, Zeng X, Robbins DJ. Sonic hedgehog as a mediator of long-range signaling. BioEssays 2002; 24: 157-165.
24. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques 1989; 7: 980-990.
25. Pepicelli CV, Lewis PM, McMahon AP. Sonic hedgehog regulates branching morphogenesis in the mammalian lung. Curr Biol 1998; 8 1083-1086.
26. Marigo V et al. Cloning, expression and chromosomal location of SHH and IHH, two human homologues of the Drosophila segment polarity gene Hedgehog. Genomics 1995; 28: 44-51.
27. Mason JM, Grande DA, Barcia M et al. Expression of human bone morphogenetic protein-7 in primary rabbit periosteal cells: potential utility in gene therapy for bone repair. Gene Therapy 1998; 5: 1098-1104.
28. Grande DA et al. A dual gene therapy approach to osteochondral defect repair using a bilayer implant containing BMP-7 and IGF-1 transduced periosteal cells. Trans Orthop Res Soc 2001; 26 294.
29. Stabler C, Wilks K, Sambanis A, Constantinidis I. The effects of alginate composition on encapsulated BTC3 cells. Biomaterials 2001; 22: 1301-1310.
30. Fleming JE, Cornell CN, Muschler GF. Bone cells and matrices in orthopedic tissue engineering. Orthop Clin North Am 2000; 31 357-374.
31. Rudert M. Histological evaluation of osteochondral defects; consideration of animal models with emphasis on the rabbit, experimental setup, follow-up and applied methods. Cells Tissue Organs 2002; 171: 229-240.
32. Hollinger JO, Kleinschmidt JC. The critical size defect as an experimental model to test bone repair materials. J Craniofacial Surg 1990; 1: 60-68.
33. Tsuchida H et al. Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats. J Orthoped Res 2003; 21: 44-53.
34. Frame JW. A convenient animal model for testing bone substitute materials. J Oral Surg 1980; 38: 176-180.
35. Gosain AK et al. Osteogenesis in cranial defects: reassessment of the concept of critical size and the expression of TGF-[beta] isoforms. Plast Reconsrtuct Surg 2000; 106: 360-371.
36. Kramer IR, Killey HC, Wright HC. A histological and radiological comparison of the healing of defects in the rabbit calvarium with and without implanted heterogenous anorganic bone. Arch Oral Biol 1968; 13: 1095-1106.
37. Breitbart AS et al. Gene-enhanced tissue engineering: applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene. Ann Plast Surg 1999; 42: 488-495.
38. Diduch DR, Jordan LC, Mierisch CM, Balian G. Marrow stromal cells embedded in alginate for repair of osteochondral defects. J Arthroscop Relat Surg 2000; 16: 571-577.
39. Milla E et al. Poly(L-lactide) acid/alginate composite membranes for guided tissue regeneration. J Biomed Mater Res 2001; 57: 248-257.
40. Loebsack A et al. In vivo characterization of a porous hydrogel material for use as a tissue bulking agent. J Biomed Mater Res 2001; 57: 575-581.
41. Shang Q et al. Tissue-engineered bone repair of sheep cranial defects with autologous bone marrow stromal cells. J Craniofac Surg 2001; 12: 586-593.
42. Miralles G et al. Sodium alginate sponges with or without sodium hyaloronate: in vitro engineering of cartilage. J Biomed Mater Res 2001; 57: 268-278.
43. Murphy MG et al. The effects of rhBMP-2 on human osteosarcoma cells and gingival fibroblasts in vitro. J Oral Implantol 2001; 27: 16-24.
44. Krebsbach PH, Gu K, Franceschi RT, Rutherford RB. Gene therapy-directed osteogenesis: BMP-7 transduced human fibroblasts form bone in vivo. Hum Gene Ther 2000; 11: 1201-1210.
45. Zuk PA et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211-228.
46. Gysin R et al. Ex vivo gene therapy with stromal cells transduced with a retroviral vector containing the BMP4 gene completely heals critical size calvarial defect in rats. Gene Therapy 2002; 9: 991-999.
47. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 1988; 62: 1120-1124.
48. Miller AD, Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 1986; 6: 2895-2902.